Doptelet Approved for Liver Disease Patients Slated for a Medical Procedure

MONDAY, May 21, 2018 — Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure.
People with ongoing liver disease often have…
Source: Topamax